Deoxyribonuclease II is a lysosomal barrier to transfection.

DNA delivered in nonviral vectors or as naked DNA must overcome a number of extracellular and intracellular barriers to transfection. Since many vectors deliver DNA into cells by the endocytic route, DNA degradation by lysosomal nucleases has been proposed as a significant barrier to transfection, despite the fact that this has not yet been formally demonstrated to occur. To test this hypothesis, we have investigated the role of deoxyribonuclease II (DNase II), the primary acidic endonuclease active in the lysosome, in transfection. Two genetic systems were engineered in which mammalian cells either overexpressed DNase II or were knocked out for the enzyme. In both models, higher levels of DNase II correlated with decreased transfection efficiency by nonviral DNA delivery vectors. These data provide direct evidence implicating lysosomal DNase II as a barrier to transfection.

[1]  M. Cotten,et al.  Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Williams,et al.  Chloroquine inhibition of repair of DNA damage induced in mammalian cells by methyl methanesulfonate. , 1974, Mutation research.

[3]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. , 1995, Human gene therapy.

[4]  I. Zuhorn,et al.  Lipoplex-mediated Transfection of Mammalian Cells Occurs through the Cholesterol-dependent Clathrin-mediated Pathway of Endocytosis* , 2002, The Journal of Biological Chemistry.

[5]  P. Meikle,et al.  Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. , 1997, Clinical chemistry.

[6]  R. Roberts,et al.  Overexpression of uteroferrin, a lysosomal acid phosphatase found in porcine uterine secretions, results in its high rate of secretion from transfected fibroblasts. , 1993, Biology of reproduction.

[7]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[8]  F. Orson,et al.  Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. , 1999, Human gene therapy.

[9]  R. Desnick,et al.  Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion , 1992, The Journal of cell biology.

[10]  F. Szoka,et al.  Phage display selection of a peptide DNase II inhibitor that enhances gene delivery , 2001, The journal of gene medicine.

[11]  D. Friend,et al.  Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. , 1996, Biochimica et biophysica acta.

[12]  D. Escande,et al.  Ca2+‐sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids , 2001, The journal of gene medicine.

[13]  K. Suzuki,et al.  Enhanced reporter gene expression in cells transfected in the presence of DMI-2, an acid nuclease inhibitor , 1998, Gene Therapy.

[14]  B Poole,et al.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Lukács,et al.  Analysis of differential lipofection efficiency in primary and established myoblasts. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  S. Cohen,et al.  SPECTROPHOTOMETRIC STUDIES OF THE INTERACTION OF CHLOROQUINE WITH DEOXYRIBONUCLEIC ACID. , 1965, The Journal of biological chemistry.

[17]  W. Sly,et al.  Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. , 1997, The Journal of clinical investigation.

[18]  K. Mechtler,et al.  Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Uyeda,et al.  DMI-2 and DMI-3, DNA methyltransferase inhibitors produced by Streptomyces sp. strain no. 560. , 1996, Journal of enzyme inhibition.

[20]  H. Luthman,et al.  High efficiency polyoma DNA transfection of chloroquine treated cells. , 1983, Nucleic acids research.

[21]  S. Fiering,et al.  Deoxyribonuclease IIα is required during the phagocytic phase of apoptosis and its loss causes perinatal lethality , 2002, Cell Death and Differentiation.

[22]  A. Eastman,et al.  Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. , 1993, Archives of biochemistry and biophysics.

[23]  C. Kerr.  Diagnosis of lysosomal storage disorders , 1984, The Medical journal of Australia.

[24]  P. Seglen.  Inhibitors of lysosomal function. , 1983, Methods in enzymology.

[25]  W. Sly,et al.  Transgene produces massive overexpression of human β-glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Chang,et al.  Intracellular distribution of DNA internalized through calcium phosphate precipitation. , 1990, Experimental cell research.

[27]  A. Eastman,et al.  The Cloning and Expression of Human Deoxyribonuclease II , 1998, The Journal of Biological Chemistry.

[28]  M. Horwitz,et al.  On the mechanism of DNA transfection: efficient gene transfer without viruses , 1997, Gene Therapy.

[29]  Hui-Ling Chen,et al.  Porcine Spleen Deoxyribonuclease II , 1998, The Journal of Biological Chemistry.

[30]  S. Tanuma,et al.  DLAD, a novel mammalian divalent cation-independent endonuclease with homology to DNase II. , 1999, Nucleic acids research.

[31]  K. Baker,et al.  Molecular cloning and characterization of human and murine DNase II. , 1998, Gene.